EU project develops software to improve brain tumour diagnosis

A recently launched EU funded HealthAgents project (and recent Best IST Project Website Award winner) is developing software which is likely to give doctors everywhere much-needed help in the early diagnosis and treatment of brain tumours.

Brain tumours remain an important cause of mortality and afflict a large percentage of the European population. In children over one year of age, brain tumours are the most common solid malignancies that cause disease-related death.

A brain tumour diagnosis usually involves using Magnetic Resonance Spectroscopy (MRS), a non-invasive technique, to determine the tissue biochemical composition of a tumour. But such scans only achieve 60-90% accuracy, depending on the tumour type and grade.

Diagnosing a tumour, therefore, also requires taking a surgical biopsy, which can be potentially deadly for patients. For tumours that evolve slowly - mainly in children - repeated biopsies are often needed, but are not advisable.

Now, research teams from Belgium, Italy, Spain and the UK, working together in HealthAgents - a €4.5 initiative - hope that with their software, biopsies will no longer be necessary.

They will develop a database in which hi-tech scans, conducted on patients in hospitals from all around Europe, may be stored and classified. Using pattern recognition techniques, the system will enable doctors to compare the scan results with those from similar cases from other hospitals. The software will then suggest a series of diagnoses, leaving the doctor to choose the best type of treatment.

According to Dr Andrew Peet, clinical advisor to HealthAgents, the project gives doctors access to a range of securely held results that would simply not have been available previously. "The consortium encompasses a wide range of talent from universities, companies and hospitals. The expertise of the consortium will provide the foundations for the first EU grid for brain tumour diagnosis and prognosis. We will profit from a world-class data exchange network to address one of the most pernicious diseases of our time," he said.

For further information, please visit:
www.healthagents.net

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...